Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China.

To evaluate the efficacy and safety of SBRT for localized prostate cancer (PCa) with CyberKnife in China. Moreover, it is the largest-to-date pilot study to report 5-year outcomes of SBRT for localized PCa from China.